Bullbear Buffett : Pentamaster

Sunday, 7 June 2026

Pentamaster

Final Comment:

Pentamaster appears to have bottomed in early 2025 and is now in a recovery phase. The annual 2025 results were weak, but quarterly trends through Q1 2026 are encouraging. Investors should watch for:

Full-year 2026 guidance from management
Whether the Q4 2025 gross margin expansion is sustainable or a one-off
Reduction in D&A growth or stabilization of capex

The stock’s valuation will depend on whether this recovery translates into sustainable double-digit net income growth after two years of declines. The current run-rate suggests 2026 net income could recover to MYR 70–80 million, still below 2023’s MYR 89 million peak.

=====

Overview of Pentamaster's Business and Operational Context

Pentamaster Corporation Berhad is a Malaysia-based automation manufacturing and technology solutions provider, operating primarily through two core segments: Automated Test Equipment (ATE) and Factory Automation Solutions (FAS), with a smaller Smart Control Solution Systems segment and a newly established healthcare operation. The ATE segment focuses on designing and manufacturing standard and non-standard automated testing equipment for industries including automotive, semiconductor and electro-optical applications, while the FAS segment provides customised robotics manufacturing systems and integrated automation solutions. Pentamaster's highest-ever revenue and profit were achieved in 2023, after which the company entered a cyclical downturn before staging a recovery beginning in late 2025.

Five-Year Annual Income Statement Analysis (2021–2025)

Revenue Performance: A Clear Peak-and-Decline Cycle

Pentamaster's five-year revenue trajectory tells a story of post-COVID recovery followed by two consecutive years of contraction. Revenue grew from MYR 508.4 million in 2021 to MYR 600.6 million in 2022 (up 18.1%), reaching a peak of MYR 691.9 million in 2023 (up 15.2%). However, 2024 saw revenue decline by 10.0% to MYR 623.0 million, followed by a further 6.3% drop in 2025 to MYR 583.7 million. This decline has been attributed to softer demand across key end-markets, particularly an automotive slowdown that began impacting results in 2024 and continued into 2025.

Profitability: Margins Proving Remarkably Resilient Despite Revenue Declines

Despite the challenging top-line environment, Pentamaster's gross profit margin has remained relatively stable throughout the five-year period. Gross margin stood at approximately 30.0% in 2021 and 2023, moderated slightly to 28.7% in 2024 before recovering to 29.4% in 2025. Similarly, EBITDA margin expanded from 20.6% in 2021 to 22.6% in 2023, contracted to 19.9% in 2024, and recovered to 21.5% in 2025. This resilience suggests that management has successfully controlled direct costs even as revenue has fallen, maintaining operational discipline through the downturn.

Net income performance, however, tells a more challenging story. Net profit after minority interest peaked at MYR 89.1 million in 2023, then fell 26.8% to MYR 65.2 million in 2024, and declined a further 5.0% to MYR 62.0 million in 2025. The sharp 27% decline in net income in 2024 was disproportionately severe relative to the 10% revenue drop, indicating significant margin compression or one-off cost pressures during that year. Basic earnings per share followed a similar path: MYR 0.10 in 2021, MYR 0.12 in 2022, MYR 0.13 in 2023, and then MYR 0.09 in both 2024 and 2025.

Expenses and Non-Operating Items: Areas of Concern

Two expense trends warrant particular attention. Depreciation and amortisation expense has risen sharply from MYR 17.5 million in 2023 to MYR 21.4 million in 2024 and further to MYR 28.2 million in 2025 — a 61% increase over just two years. This reflects significant recent capital expenditure, likely related to the completion of Campus 3 and other capacity expansion initiatives that management has indicated should start generating returns in 2026.

Non-operating income and expense has also been highly volatile, swinging from a positive contribution of MYR 27.4 million in 2021 to a negative MYR 17.4 million in 2023, MYR 5.2 million negative in 2024, and MYR 12.6 million negative in 2025. This volatility introduces significant unpredictability into reported earnings, making underlying operating performance difficult to assess from headline net income figures alone.

Minority Interest: A Persistent Drag on Shareholder Returns

An important but often overlooked feature of Pentamaster's financial structure is the substantial minority interest expense. Consolidated net income for the group was MYR 90.7 million in 2025, but after deducting minority interests of MYR 28.8 million, net income attributable to ordinary shareholders was only MYR 62.0 million. This pattern has persisted throughout the five-year period, with minority interest typically representing 28% to 38% of consolidated net income. Core shareholders thus capture only a portion of the group's operational earnings.

Latest Five Quarters Income Statement Analysis (Q1 2025 – Q1 2026)

Revenue Recovery: Four Consecutive Quarters of Sequential Growth

The quarterly data reveals a clear turnaround that is not yet visible in the full-year annual figures. Starting from a trough of MYR 131.6 million in Q1 2025, revenue has risen sequentially for four consecutive quarters. Q2 2025 revenue reached MYR 144.9 million (up 10.1% QoQ), followed by MYR 148.1 million in Q3 2025 (up 2.2% QoQ) and MYR 159.1 million in Q4 2025 (up 7.5% QoQ). The recovery accelerated significantly in Q1 2026, with revenue surging 13.4% to MYR 180.4 million — the highest quarterly revenue achieved in over two years.

The Q1 2026 revenue increase of 37% year-on-year was primarily driven by the Factory Automation Solutions segment, where revenue more than doubled from a year earlier, led by stronger project deliveries related to smartphone assembly and testing applications for a major customer. In contrast, the ATE segment revenue declined nearly 9% year-on-year due to lower contributions from higher-margin automotive and electro-optical segments.

Profitability Volatility and the Healthcare Segment Challenge

Despite strong revenue growth, profitability trends have been more uneven. Net income improved from MYR 13.1 million in Q1 2025 to MYR 20.2 million in Q4 2025, with net margins expanding from 9.9% to 12.7% over that period. However, Q1 2026 net income of MYR 17.9 million fell short of Q4 2025 levels despite higher revenue, with the net margin retracing to 9.9%.

The primary drag on profitability in Q1 2026 was the newly commercialised healthcare segment, which manufactures single-use medical devices and incurred losses due to high fixed costs during its early-stage commercialisation phase. Management has guided that the healthcare segment is likely to remain loss-making throughout 2026, requiring annual revenue of approximately MYR 50 million to cover operating costs of MYR 30 million per year before achieving breakeven in 2027.

Acknowledged Reporting Anomaly in Q4 2025

The quarterly data contains a clear reporting anomaly: Q4 2025 EBITDA is shown as MYR 4.97 billion and SG&A as a negative MYR 4.90 billion, neither of which is plausible given the company's annual revenue of approximately MYR 583 million. The net income figure of MYR 20.2 million (reflecting a 12.7% net margin) is, however, consistent with the company's typical margin profile and should be considered the reliable metric for that quarter.

Outlook and Forward-Looking Commentary

Order Book Strength and Strategic Pivot

Pentamaster's order book has strengthened considerably, rising from RM400 million in Q2 2025 to RM450 million in Q3 2025 and further to RM480 million in Q1 2026 . The order book is now predominantly driven by the FAS segment, which makes up 84% of the total, with medical end-markets contributing 55% and consumer/industrial applications contributing 24%.

Management has indicated that the group expects to achieve double-digit revenue growth in 2026, with revenue potentially exceeding the RM700 million mark, supported by the RM400 million order backlog scheduled for delivery in the first half of 2026. The group is strategically pivoting from the cooling electric vehicle market—which is expected to drop from approximately 40% of revenue in 2025 to just 10% in 2026—toward factory automation, medical applications, AI servers (targeting 15% of revenue) and advanced chip packaging (targeting 10% of revenue).

Analyst Views and Risk Factors

Kenanga Research expects Pentamaster's financial year 2026 to remain anchored by FAS, with the segment expected to contribute over 50% of revenue, while the ATE segment could benefit from AI and high-performance computing demand and the commercialisation of its "9 Samurai" advanced packaging projects. However, near-term earnings face pressure from the weaker ATE segment performance in Q1 2026 and ongoing losses from the healthcare segment, which have led several research houses to downgrade their calls to "hold".

Additional risks include the expiry of pioneer status for a key subsidiary on 31 March 2026, with a new application pending review by MIDA, which could affect future tax expenses, and the ongoing patent dispute with Ocado Innovation Limited, although management does not expect a material financial impact.

Concluding Assessment

Pentamaster has navigated a challenging two-year cyclical downturn with notable operational discipline, maintaining gross margins around 29% despite consecutive revenue declines. The company now appears to be firmly in a recovery phase, supported by a strengthening order book, strategic reorientation away from the struggling EV market, and the completion of a RM300 million capital expenditure programme that management expects to begin generating returns in 2026. The key risks to monitor are the pace at which the healthcare segment reaches breakeven, the successful commercialisation of the advanced packaging product suite, and the resolution of the tax incentive renewal. For investors, the trajectory remains one of cautious optimism — the recovery is real and well-supported, but full-year 2026 profitability will be heavily influenced by factors outside the company's immediate control, including global semiconductor demand and the timing of project deliveries across its diverse end-markets.

No comments:

My 18 points guide to Successfully compounding your money in Stocks

Be a good stock picker.
Think as a business owner.
Always look at value rather than the price. Do the homework.
Buy and hold is alright for selected stocks.
Compounding is your friend, get this to work its magic.
Mr. Market is there to be taken advantage of. Do not be the sucker instead. BFS;STS.
Always buy a lot when the price is low.
Never buy when the stock is overpriced.
It is alright to buy when the selected stock is at a fair price.
Phasing in or dollar cost averaging is safe for such stocks during a downtrend, unless the price is still obviously too high.
Do not time the market for such or any stocks.
By keeping to the above strategy, the returns will be delivered through the growth of the company's business.
So, when do you sell the stock? Almost never, as long as the fundamentals remain sound and the future prospects intact.
The downside risk is protected through only buying when the price is low or fairly priced.
Tactical dynamic asset allocation or rebalancing based on valuation can be employed but this sounds easier than is practical, except in extreme market situations.
Sell urgently when the company business fundamental has deteriorated irreversibly.
You may also wish to sell should the growth of the company has obviously slowed and you can reinvest into another company with greater growth potential of similar quality. However, unlike point 16, you can do so leisurely.
In conclusion, a critical key to successful investing is in your stock picking ability.

http://myinvestingnotes.blogspot.com/2012/07/my-18-points-guide-to-successfully.html

11 Lessons From Peter Lynch

Peter Lynch taught me:

1. Behind every stock is a company. Find out what it’s doing.
2. Never invest in any idea you can’t illustrate with a crayon.
3. Over the short term, there may be no correlation between the success of a company’s operations and the success of its stock. Over the long term, there’s a 100% correlation.
4. Buying stocks without studying the companies is the same as playing poker – and never looking at your cards.
5. Time is on your side when you own shares of superior companies.
6. Owning stock is like having children. Don’t get involved with more than you can handle.
7. When the insiders are buying, it’s a good sign.
8. Unless you’re a short seller, it never pays to be pessimistic.
9. A stock market decline is as predictable as a January blizzard in Colorado. If you’re prepared, it can’t hurt you.
10. Everyone has the brainpower to make money in stocks. Not everyone has the stomach.
11. Nobody can predict interest rates, the future direction of the economy, or the stock market. Dismiss all such forecasts and concentrate on what’s actually happening to the companies in which you’ve invested.

Lynch’s advice had a profound effect on my stock market approach. He taught me that investment success isn’t the result of developing the right macro-economic view or deciding when to jump in or out of the market. Success is about researching companies to identify those that are likely to report positive surprises.

Capital Expenditure

A great company with a Durable Competitive Advantage will have a ratio of Capital Expenditures to Net Income of less than 25%. Less is better.

Capital Expenditures are expenses on:
- fixed assets such as equipment, property, or industrial buildings
- fixing problems with an asset
- preparing an asset to be used in business
- restoring property
- starting new businesses

A good company will have a ratio of Capital Expenditures to Net Income of less than 50%.

A great company with a Durable Competitive Advantage will have a ratio of less than 25%.

Less is better.

Benjamin Graham's 113 Wise Words

The true investor scarcely ever is forced to sell his shares, and at all times he is free to disregard the current price quotation. He need pay attention to it and act upon it only to the extent that it suits his book, and no more. Thus the investor who permits himself to be stampeded or unduly worried by unjustified market declines in his holdings is perversely transforming his basic advantage into a basic disadvantage. That man would be better off if his stocks had no market quotation at all, for he would then be spared the mental anguish caused him by other persons' mistakes of judgement."

Philip Fisher's Wise Words

"The refusal to sell at a loss, while completely natural and normal, is probably one of the most dangerous in which we can indulge ourselves in the entire investment process.

More money has probably been lost by investors holding a stock they really did not want until they could 'at least come out even' than from any other single reason. If to these actual losses are added the profits that might have been made through the proper reinvestment of these funds if such reinvestment had been made when the mistake was first realized, the cost of self-indulgence becomes truly tremendous."

(Common Stocks and Uncommon Profits)

The Ultimate Hold-versus-Sell Test

Here is the overriding primary test, followed by observations on why it is so critically important:

Knowing all that you now know and expect about the company and its stock (not what you originally believed or hoped at time of purchase), and assuming that you had available capital, and assuming that it would not cause a portfolio imbalance to do so, would you buy this stock today, at today's price?

No equivocation. Yes or no?

Answers such as maybe or probably are not acceptable since they are ways of dodging the issue. No investor probably buys a stock; they either place an order or do not.

Here is the implication of your answer to that critical test: if you did not answer with a clear affirmative, you should sell; only if you said a strong yes, are you justified to hold.

Some thoughts on Analysing Stocks (KISS)

Ideally a stock you plan to purchase should have all of the following charateristics:

• A rising trend of earnings dividends and book value per share.
• A balance sheet with less debt than other companies in its particular industry.
• A P/E ratio no higher than average.
• A dividend yield that suits your particular needs.
• A below-average dividend pay-out ratio.
• A history of earnings and dividends not pockmarked by erratic ups and downs.
• Companies whose ROE is 15 or better.
• A ratio of price to cash flow (P/CF) that is not too high when compared to other stocks in the same industry.

Margin of Safety Concept: Stocks should be bought like groceries, not like perfume

The high CAGR in the early years of the investing period, due to buying at a discount, tended to decline and approach that of the intrinsic EPS GR of the companies over a longer investment time-frame.

Chapter 20 - “Margin of Safety” as the Central Concept of Investment

A single quote by Graham on page 516 struck me:

Observation over many years has taught us that the chief losses to investors come from the purchase of low-quality securities at times of favorable business conditions.

Basically, Graham is saying that most stock investors lose money because they invest in companies that seem good at a particular point in time, but are lacking the fundamentals of a long-lasting stable company.

This seems obvious on the surface, but it’s actually a great argument for thinking more carefully about your individual stock investments. If most of your losses come from buying companies that seem healthy but really aren’t, isn’t that a profound argument for carefully studying any company you might invest in?

Bullbear Buffett